Market Access Why the NHS remains the world's most challenging – and rewar... For pharmaceutical, biotech, and medtech companies eyeing global expansion, the NHS presents a paradox.
News J&J scores EU approval for Tecvayli combo in second line Johnson & Johnson's multiple myeloma regimen is now approved as a second line treatment in both the US and the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
